TXO Partners LP is not a good buy right now for a Beginner, long-term investor with $50,000-$100,000 to deploy. The stock is trading below its recent pivot and momentum is only weakly improving, while options sentiment is mildly bullish but not strong enough to override the lack of a clear trend and the absence of fresh catalysts. For an inpatient investor, this is better treated as a hold than an immediate buy.
TXO is showing a mixed-to-weak technical setup. Current price is 13.24, below the pivot at 14.249 and also below resistance levels at 14.585 and 14.793, which suggests the stock has not yet reclaimed a constructive trend. MACD histogram is slightly positive at 0.0148 but is contracting, so momentum is fading rather than accelerating. RSI_6 at 35.67 is neutral-to-weak, indicating the stock is not oversold enough to signal a strong reversal. Moving averages are converging, which often points to indecision. The short-term pattern estimate also leans negative, with a 60% chance of declines over the next day, week, and month.

The earlier target increase to $23 from $18 suggests analysts have viewed TXO favorably on improved crude pricing and transaction-related developments. Options open interest also leans bullish via a low put-call ratio. There is no fresh negative news in the past week.
There has been no recent news in the last week, so there is no near-term event catalyst to drive the stock higher. Hedge funds have been selling heavily, with selling up 3805.93% over the last quarter, which is a meaningful negative signal. The technical setup is weak, with price below pivot and resistance levels, fading MACD momentum, and a short-term pattern bias toward declines. There is also no recent congress trading activity to support bullish sentiment.
Latest quarter financial data was not available because the financial snapshot returned an error, so a quarter-by-quarter fundamental review cannot be completed from the provided data. That means there is no confirmed recent revenue, earnings, or distribution growth trend to support a long-term buy decision from fundamentals alone.
Analyst sentiment is still positive overall. Raymond James maintained a Strong Buy rating on TXO and currently has a $22 target, though it was reduced from $23 on a more conservative distribution outlook. Before that, Raymond James had raised the target from $18 to $23 following stronger crude prices and the Cross Timbers divestiture. Net-net, Wall Street pros are still constructive, but the target revision shows slightly less optimism than before.